Thanks for posting the chart. Brilicidin is going to be huge. You are very knowledgable all things CTIX. Do you think the long delay of information for Cohort 7 has anything to do with Dana Farber wanting the FDA to fast track Kevetrin due to efficacy across all tested cancers?